Cook Incorporated Continues to Revolutionize
Endovascular Aortic Repair Procedure

Bloomington, IN - Cook Incorporated, the largest privately held medical device manufacturer in the world, today announced the availability of the CODA balloon catheter to the endovascular market. The new catheter is designed for temporary occlusion of large blood vessels and expanding vascular prostheses. With its unique configuration, CODA helps to optimize stent graft geometry after implantation of an endograft during endovascular aortic repair (EVAR). EVAR is a minimally invasive procedure to treat abdominal aortic aneurysms (AAA), one of the leading causes of death in the U.S.

The new catheter is enhanced by a long, tapered tip design that offers excellent over-the-wire trackability enabling physicians to minimize blood vessel trauma. The bi-lumen shaft is engineered to provide additional support during EVAR procedures and to facilitate rapid balloon inflation and deflation rates.

CODA is constructed with latex-free balloon material to reduce possible allergic reactions in patients with hypersensitivity to latex. CODA has 100 cm of usable length and can be expanded to a maximum diameter of 32 mm, enabling physicians to easily work with blood vessels of varying size and shape to 40 mm.

"CODA illustrates our vision of revolutionizing Endovascular Aortic Repair," said Barry Thomas, director of endovascular therapies at Cook. "It deflates faster than other comparable balloon catheters and provides the physician with more ability for precise positioning during an EVAR procedure than ever before. This means procedures can be done very efficiently, which could potentially reduce risks to the patient."

Availability
The CODA Balloon Catheter from Cook is currently available for shipment.

About Cook Incorporated
With international headquarters in Bloomington, Ind., COOK®, the world's largest privately held medical device manufacturer, is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, Cook has created innovative technologies for stents and stent-grafts, catheters, wire guides, introducer needles and sheaths, embolization coils, medical biomaterials, vena cava filters, implanted cardiac lead extraction equipment and other minimally invasive medical devices.

MEDIA CONTACT:
David McCarty
Director of Public Relations
Cook Incorporated - 812-339-2235 ext. 2387
Email: dmccarty@cook-inc.com

Back to Previous Page